Health Condition 1: Z209- Contact with and (suspected) exposure to unspecified communicable disease
Conditions
Interventions
Intervention1: Celevida MaXX Enteral Nutrition Formula: Dose: CELEVIDA MAXX EN is an Enteral and oral nutritional
supplement (Dr. Reddy’s Laboratories). This product is designed to deliver 1 to 2 Kca
Sponsors
Dr Reddys Laboratories
Eligibility
Inclusion criteria
Inclusion criteria: 1) To study the impact of tube feeding supplement for achieving the target Macro Nutrients levels 2) To study the number of days required to reach the target Macro Nutrients levels
Exclusion criteria
Exclusion criteria: 1) To study the impact of EN supplement on total protein, micronutrient levels such as Zn, Vitamin C, Mg, potassium and Phosphorous. 2) To study the impact of tube feeding supplement events of abdominal pain, distension, vomiting and diarrhea after EN supplement 3) To assess the number and reasons of interruptions during the tube feeding and ease of titration of the formula 4) To assess the impact of tube feeding supplement on hematological parameters from baseline to the end of the study. 5) To evaluate the palatability of the formulation in patients shifted to ward’s, through oral supplementation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Ease of achieving desired target, no. of days required to achieve the target and no. of days of ICU stay. Timepoint: Baseline Visit, Day 1, Day 2, Day 3, Day 4-8, Day 8-14, End of study assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Improved vital status 2) No Interruptions to feeding 3) Absence of GIT complications- abdominal distention, vomiting and pain post starting of EN 4) Biochemical profile changes like blood glucose, BUN, LFT, Serum Pre albumin Levels 5) Palatability of the powder in ward patientsTimepoint: Baseline Visit, Day 1, Day 2, Day 3, Day 4-8, Day 8-14, End of study assessment. | — |
Countries
India
Contacts
Public ContactDr Rahul Rathod
Dr Reddys Laboratories
Outcome results
None listed